Clinical Trial Update: Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on Dornase Alfa therapy for pulmonary infections in neonates on ventilators, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Infections in Neonates
• Ventilator-associated Pneumonia

Drugs mentioned

• Dornase alfa (dornase alfa)

Snippet

Sponsor: Georgetown University | Conditions: Pulmonary Infections | Phase 4 | Status: COMPLETED | Results posted: 2017-02-08